A Novel Biomarker - Heart Type Fattyacid Binding Protein (H-FABP) in Patient with Acute Coronary Syndrome

Praneeth Chowdary.T, G. S. Shiddapur, Sumith.K, Kunal.O

Abstract: Background: Acute coronary syndrome (ACS) is one among the foremost common reason for death in India and also the leading reason for death worldwide. Cardiac biomarkers have had a waggish shock on the superintendence of this disease and are now a pivotal factor in diagnosis and prognosis. Material and methods: two year cross-sectional study was done among 60 patients presenting with signs and symptoms suggestive of acute coronary syndrome were enrolled as study participants. Results: Out of 60 ACS cases 25 (41.67 %) were presented within 4 hours of onset of symptoms and 100 % had complaint of chest pain followed by breathlessness 25 %and palpitation 15 %. acute myocardial infarction was found in 28.33 %. efficacy of H-FABP among AMI and Non-AMI patient during the time interval of 0 to 24 hours has got good sensitivity and had statistical significance with p

Keywords: ACS, Cardiac biomarkers, H-FABP

How to Cite?: Praneeth Chowdary.T, G. S. Shiddapur, Sumith.K, Kunal.O, "A Novel Biomarker - Heart Type Fattyacid Binding Protein (H-FABP) in Patient with Acute Coronary Syndrome", Volume 8 Issue 3, March 2019, International Journal of Science and Research (IJSR), Pages: 131-134, https://www.ijsr.net/getabstract.php?paperid=ART20195654, DOI: https://dx.doi.org/10.21275/ART20195654